Group X secretory PLA2 in neutrophils plays a pathogenic role in abdominal aortic aneurysms in mice.

Group X secretory PLA(2) (sPLA(2)-X) is expressed in neutrophils and plays a role in the pathogenesis of neutrophil-mediated tissue inflammation and injury. This study tested the hypothesis that sPLA(2)-X in neutrophils may contribute to the pathogenesis of abdominal aortic aneurysms (AAA) using sPLA(2)-X(-/-) mice. AAA was created by application of CaCl(2) to external surface of aorta. As a result, the aortas of sPLA(2)-X(-/-) mice had smaller diameters (percent increase from baseline; 24.8 ± 3.5% vs. 49.9 ± 9.1%, respectively; P < 0.01), a reduced grade of elastin degradation, and lower activities of elastase and gelatinase (26% and 19% lower, respectively) after CaCl(2) treatment compared with sPLA(2)-X(+/+) mice. In sPLA(2)-X(+/+) mice, immunofluorescence microscopic images showed that the immunoreactivity of sPLA(2)-X was detected only in neutrophils within aortic walls 3 days, 1, 2, and 6 wk after CaCl(2) treatment, whereas the immunoreactivity was not detected in macrophages or mast cells in aortic walls. sPLA(2)-X immunoreactivity also was colocalized in cells expressing matrix metalloproteinase (MMP)-9. Neutrophils isolated from sPLA(2)-X(-/-) mice had lower activities of elastase, gelatinase, and MMP-9 in response to stimuli compared with sPLA(2)-X(+/+) mice. The attenuated release of elastase and gelatinase from sPLA(2)-X(-/-) neutrophils was reversed by exogenous addition of mouse sPLA(2)-X protein. The adoptive transfer of sPLA(2)-X(+/+) neutrophils days 0 and 3 after CaCl(2) treatment reversed aortic diameters and elastin degradation grades in the lethally irradiated sPLA(2)-X(+/+) mice reconstituted with sPLA(2)-X(-/-) bone marrow to an extent similar to that seen in sPLA(2)-X(+/+) mice. In conclusion, sPLA(2)-X in neutrophils plays a pathogenic role in AAA in a mice model.

[1]  M. Gelb,et al.  Group X Secretory Phospholipase A2 Enhances TLR4 Signaling in Macrophages , 2011, The Journal of Immunology.

[2]  A. Gabrielsen,et al.  Increased expression of leukotriene C4 synthase and predominant formation of cysteinyl-leukotrienes in human abdominal aortic aneurysm , 2010, Proceedings of the National Academy of Sciences.

[3]  Jean-Baptiste Michel,et al.  Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.

[4]  M. Gelb,et al.  Group X Secretory Phospholipase A2 Negatively Regulates ABCA1 and ABCG1 Expression and Cholesterol Efflux in Macrophages , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Waters,et al.  Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. , 2010, Journal of the American College of Cardiology.

[6]  M. Triggiani,et al.  Lung mast cells are a source of secreted phospholipases A2. , 2009, The Journal of allergy and clinical immunology.

[7]  J. Michel,et al.  Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophilderived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  J. H. van Bockel,et al.  Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic T Cells , 2009, Circulation.

[9]  Heather L Rick,et al.  Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE−/− Mice , 2009, Journal of cardiovascular pharmacology.

[10]  Takamitsu Nakamura,et al.  Reduction in Myocardial Ischemia/Reperfusion Injury in Group X Secretory Phospholipase A2–Deficient Mice , 2008, Circulation.

[11]  Robert W. Thompson,et al.  Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms , 2007, Proceedings of the National Academy of Sciences.

[12]  G. le Naour,et al.  Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  W. Cho,et al.  Systematic Evaluation of Transcellular Activities of Secretory Phospholipases A2 , 2006, Journal of Biological Chemistry.

[14]  M. Murakami,et al.  Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. , 2005, Biochimica et biophysica acta.

[15]  T. Wakefield,et al.  L-Selectin–Mediated Neutrophil Recruitment in Experimental Rodent Aneurysm Formation , 2005, Circulation.

[16]  B. Baxter,et al.  Elastin Degradation and Calcification in an Abdominal Aorta Injury Model: Role of Matrix Metalloproteinases , 2004, Circulation.

[17]  Makoto Murakami,et al.  Secretory phospholipase A2. , 2004, Biological & pharmaceutical bulletin.

[18]  B. L. Diaz,et al.  Phospholipase A(2). , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[19]  J. Balsinde,et al.  Phospholipase A2 regulation of arachidonic acid mobilization , 2002, FEBS letters.

[20]  Katsutoshi Yamada,et al.  Potent Modification of Low Density Lipoprotein by Group X Secretory Phospholipase A2 Is Linked to Macrophage Foam Cell Formation* , 2002, The Journal of Biological Chemistry.

[21]  M. Gelb,et al.  Groups IV, V, and X Phospholipases A2s in Human Neutrophils , 2002, The Journal of Biological Chemistry.

[22]  W. Pearce,et al.  Murine aortic aneurysm produced by periarterial application of calcium chloride. , 2001, The Journal of surgical research.

[23]  M. Murakami,et al.  Cellular components that functionally interact with signaling phospholipase A(2)s. , 2000, Biochimica et biophysica acta.

[24]  N. Fujii,et al.  Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. , 2000, Archives of biochemistry and biophysics.

[25]  M. Gelb,et al.  Exogenously Added Human Group X Secreted Phospholipase A2 but Not the Group IB, IIA, and V Enzymes Efficiently Release Arachidonic Acid from Adherent Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[26]  K. Kawamoto,et al.  Purified Group X Secretory Phospholipase A2 Induced Prominent Release of Arachidonic Acid from Human Myeloid Leukemia Cells* , 1999, The Journal of Biological Chemistry.

[27]  M. Gelb,et al.  On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes. , 1999, The Journal of biological chemistry.

[28]  J. Tischfield A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals* , 1997, The Journal of Biological Chemistry.

[29]  J. Mudgett,et al.  A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains (*) , 1995, The Journal of Biological Chemistry.

[30]  P. Braquet,et al.  Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet‐activating factor in human neutrophils , 1994, British journal of pharmacology.

[31]  S. Parikh,et al.  Role of the Neutrophil in Abdominal Aortic Aneurysm Development , 1993, Cardiovascular surgery.

[32]  M. Gelb,et al.  Group X secretory phospholipase A(2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. , 2011, Atherosclerosis.

[33]  N. Weintraub,et al.  Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[34]  A. Daugherty,et al.  Abdominal Aortic Aneurysms : Pathophysiological Mechanisms and Clinical Implications , 2004 .

[35]  E. Dennis,et al.  Phospholipase A2 , 1990, Advances in Experimental Medicine and Biology.